MEDS (TRxADE) Gross Margin

Official company branding of TRxADE Health Corp (MEDS)

Does the minimal ecological footprint of TRxADE HEALTH, Inc. (MEDS) cloud business impact its market capitalization? New SaaS products and the digitalization of pharmaceutical procurement are driving the rise in share prices. The automation of pharmacy supply chains via the IT platform confirms the model's efficiency, as evidenced by the shift in gross margin. The value of -116.50 reflects the latest metric, capturing the company's ability to protect capital from inflationary contraction.

MEDS: TRxADE Health Corp Return on Gross Profit 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for TRxADE HEALTH, Inc. (MEDS)

- stock value and consensus price forecast:
Fundamental valuation:MEDS - TRxADE HEALTH Inc
Manufactured products of TRxADE Health Corp

For an objective assessment of the issuer, it is critical for a portfolio manager to understand the profit margin after deducting direct service delivery costs. This metric measures operational efficiency, demonstrating the business's ability to convert revenue into gross income. An analysis of the consolidated gross margin allows for an evaluation of how successfully the TRxADE HEALTH (MEDS) IT platform optimizes costs while scaling procurement services for independent pharmacies.

Main competitors

VEEV - Return on Sales by Gross Profit|DOCS (Doximity Network) - Gross Margin|HQY (HealthEquity, Inc.) - Gross Profit Ratio|Gross Margin WAY|CRVL: Gross Profitability Margin|Privia Health Group - Return on Gross Profit|Huron Consulting - Gross Profitability|Certara Software - Gross Margin|Return on Sales by Gross Profit Omnicell Health OMCL|GDRX: Gross Margin|Gross Return on Sales SDGR|Gross Profitability Phreesia|Gross Return on Sales OMDA (Omada Health)|Gross Profitability Evolent Health, Inc. (EVH)|Return on Gross Profit HealthStream, Inc. HSTM|Gross Margin DH (Definitive Corp)|Return on Sales by Gross Profit consensus.com (CCSI)|AGL: Return on Gross Profit|Return on Sales by Gross Profit Absci Corporation ABSI|SY: Gross Margin|Return on Gross Profit NRC Health|Gross Profitability Spok Corp|optimizerx.com (OPRX) - Return on Sales by Gross Profit|Return on Gross Profit TBRG (TruBridge)|Return on Sales by Gross Profit Simulations Plus Inc|Gross Margin SOPH (SOPHiA GENETICS SA)|HCAT - Return on Gross Profit|CareCloud Corp - Gross Margin|Return on Sales by Gross Profit Research Solutions RSSS|DLHC (dlhcorp.com) - Return on Gross Profit|Return on Gross Profit OneMedNet Corp|Gross Profitability Scienture Holdings Inc|HCTI (Healthcare Triangle) - Gross Profit Ratio|Gross Profitability iSpecimen Corp (ISPC)|Gross Profit Ratio BFRG|Gross Profitability SCWorx WORX|MSPR - Return on Gross Profit|iCoreConnect, Inc. - Gross Margin|Gross Profit Margin Orgenesis Corporation|RCM (R1 RCM Inc.) - Return on Gross Profit|Gross Profit Margin Sharecare, Inc. (SHCR)|Gross Profitability Streamline Health|SYRA: Gross Profit Rate|Gross Profitability Apollo Medical Holdings Inc. (AMEH)|Return on Sales by Gross Profit Model N Corporation|NextGen - Return on Gross Profit